Quantcast

Radiation helps drugs ‘zero in’ on tumor blood vessels

A team of scientists has shrunk tumors or delayed their growth in animal studies by using radiation to enable a drug to “zero in” and block the tumor blood vessels. The work, reported in the January issue of the journal Cancer Cell, is a model for what might be achieved in patients by using radiation to activate drug targets in tumors. “We can now use combinations of chemotherapy and radiation to improve the anti-cancer effect for many of our patients, but the side effects can be great,” said Dr. Dennis Hallahan, chair of Radiation Oncology at Vanderbilt- Ingram. “With this approach, we hope we can ultimately deliver drugs directly and selectively to the tumor alone, and reduce side effects.”